ArticleJournal of oral biology and craniofacial research
Article in Journal of oral biology and craniofacial research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to evaluate the tear strength, anti-candidal effect, and resistance to polymicrobial biofilm formation of maxillofacial silicone modified with varying concentrations of Glycyrrhiza glabra (0 %, 1.5 %, 2.5 %, and 5 %), focusing on enhancing its durability, antimicrobial properties, and overall performance. Methods: A total of 192 samples were prepared and divided into groups based on Glycyrrhiza glabra concentrations, with further subgroups for each parameter with 48 samples in each concentration group. Tear strength was tested using a universal testing machine and expressed in N/mm. Anti-candidal and polymicrobial biofilm properties were assessed by inoculating samples with Candida albicans and a mixed culture of Candida albicans and Results: Increasing the concentration of Glycyrrhiza glabra significantly enhanced tear strength and antimicrobial properties. Tear strength improved progressively, with Group D (5 % concentration) achieving the highest value of 12.43 N/mm. Anti-candidal efficacy showed a clear dose-dependent effect, with Group D reducing Candida albicans counts from 225.75 in Group A to 40.67 at 24 h and further to 25.17 at 48 h. Polymicrobial biofilm formation also decreased significantly, with Group D showing the lowest counts of 163.33 CFU at 24 h and 163.08 CFU at 48 h. Tukey's post hoc test revealed significant differences between treatment groups ( Conclusion: The incorporation of Glycyrrhiza glabra into maxillofacial silicone significantly enhances tear strength, anti-candidal, and anti-polymicrobial properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.